India – Diabetes India

Members: 100
Page Last Updated: 15/10/2019
Website: http://www.diabetesindia.com/

Officers:

President:
Shaukat M. Sadikot

50, Manoel Gonsalves Rd.
Bandra (W)
Mumbai 400050
India
Phone: + 91 22 26557122 or 26429129
Fax: + 91 22 56571637
Chief Executive:
Anant Nigam
Nigam Diabetes Centre
a-46 Bajaj Nagar
Jaipur 392915
India
Phone: +91 141 2705303
Fax: +91 141 2706303
E-mail: dranigam@hotmail.com
Vice Presidents:
SR Aravind, Bangalore
Sarita Bajaj, Allahabad
AH Zargar, Srinagar
KM Prasanna Kuman, Bangalore
Jamal Ahmad, Aligarh

Dr. Shaukat Sadikot (1950-2019)

It is with deep sadness and regret that the International Atherosclerosis Society (IAS) announces the passing of its former Board member, Dr. Shaukat Sadikot, on October 1, 2019.

Dr. Sadikot, from India, was closely associated with the activities of IAS for many years and was chair of DiabetesIndia, one of the IAS 67 member societies. A true icon of the diabetes world, Dr. Sadikot was actively involved with the cause of diabetes and associated metabolic disorders in India, regionally and internationally for over 30 years. He was elected to the role of President-Elect of the International Diabetes Federation (IDF) in 2013 and subsequently served as President of IDF for the period 2016-2017.He worked as a Consultant in Endocrinology at the Jaslok Hospital and Research Center, Mumbai and served as President of DiabetesIndia for many years. Dr. Sadikot was instrumental in conducting the first nationwide survey on the prevalence of diabetes in India. In his capacity as Founding President of DiabetesIndia, he launched many projects for the enhancement of healthcare professional education in the field of diabetes.

Dr. Sadikot was also editor of the international scientific journal “Diabetes and the Metabolic Syndrome: Clinical Research and Reviews”, and author of four books and over 90 publications. DiabetesIndia published “Sadikot’s International Textbook of Diabetes,” which included contributions from more than 100 authors.

IAS extends its deepest condolences to Dr. Sadikot’s family and friends in this time of grief.

DIABETES INDIA

DIABETES INDIA originally named as The Indian Task Force on Diabetes Care In India was initially formed by a group of around 400 practising diabetologists and has now opened its doors to other medical specialists, family physicians, people with diabetes and all others interested in the cause of diabetes. Today we are proud to say that we have a membership of many thousands and this is increasing at a rapid pace.

Diabetes, with its attendant acute and long term complications, and the myriad of disorders associated with it, is a major health hazard. In keeping with the scenario of most developing countries, India has long passed the stage of a diabetes epidemic. To put it simply, it has crossed the dividing line in which it is a problem associated with individuals, no matter how large this number may be, and is now a very large public health problem, growing astronomically year after year.

The 1997 WHO report has shown that there is a marked increase in the number of people affected with diabetes and this trend is scheduled to grow in geometric proportions in the next couple of decades.

DIABETES INDIA recently carried out a first of its kind nationwide survey of the prevalence of diabetes and our published data shows that India has already exceeded the WHO projections.

We now have the dubious distinction of being home to the largest number of people with diabetes for any one country.

The picture was made even more grim by the fact that many of our people with diabetes are still undiagnosed. Almost two out of three people in urban areas and three out of four in rural regions have diabetes but do not know it!

Whilst the high rates of prevalence of complications is disturbing, the picture is rendered all the more gloomy with reports that many patients already show the presence of these complications at the time of diagnosis. The results of another study carried out by DIABETES INDIA seem to bear this out. What was extremely disturbing was the significant rise in premature CAD which we now see occurring even in people in the 30’s.

There is no denying that diabetes and its attendant complications is a major problem in India.

More than a matter of individual health and well being, the epidemic calls for an effort in which attention must be paid not only to treating a patient with diabetes. It involves a collective response which includes the setting up of a complete infrastructure which involves attention to prevention as well as making diabetes care “Available, Accessible and Affordable” to all persons with diabetes.

Diabetes care should be “available”, not only in terms of equipment, but, more importantly in terms of expertise. It should be “accessible” to the people without their having to travel long distances to avail of it. Importantly, such services must take into consideration the economic realities and be “affordable”.

This concept of diabetes care which is “available, accessible and affordable” to our people with diabetes is central to the aims and objectives of DIABETES INDIA.

DIABETES INDIA is very happy that many of its activities and initiatives, whether they be in the areas of education, research, clinical, community based projects have been widely appreciated. These include, amongst others, free insulin supplies for the economically deprived, prevention initiatives especially amongst schoolchildren, medical education for Family Practitioners, Physicians, Postgraduate and undergraduate students, in the form of specially focused lectures, Journals and Newsletters, and we reach around 50,000 doctors on a regular basis. We have published books on the Management of Diabetes and also books in ten Indian languages for patient education, which are now in their third print run.
We are currently working closely with about 18,000 family physicians and around 3000 physicians (internists) to look at the criteria for the diagnosis of the metabolic Syndrome in the Indian population. We now have a lot of data which shows that the criteria relevant to our people is quite different from the WHO, ADA, AACE, NCEP, the European group and even from that presented in Berlin by the IDF. What complicates the issue is that even within India, we find differences between regions which, I guess, one needs to accept considering the heterogeneity of the population. And this is in addition to the Urban-Rural divide. Unfortunately the rural population has always been neglected but when you have more than 700 million living in rural India, how long can one ignore this. This will be an ongoing project.

In addition to this, about 80 of us working in the bigger institutions and universities are looking at the relevance of the new risk factors for CVD.
We have a lot of data on hs-CRP and serum homocysteine levels, which again show levels of significance very different from the widely accepted levels.

It is on the basis of this that we have started our planning to educate people on the risks for diabetes and atherosclerosis and have roped in many people from the media which should be of immense help in spreading the knowledge.

What we are already doing is that we have set up education and preventive modules in schools especially in the bigger cities to spread knowledge about childhood obesity which is again a major problem.

In many of these activities we work closely with members of the Cardiology Society of India.
Our website www.diabetesindia.com is a forum for education and interaction and is now ranked in the first 100 by Google from 27.7 million websites when one searches with the word Diabetes, and gets around 300,000 hits per month.

All our activities have the basic focus on trying to improve and better the lives of our people with diabetes and the Metabolic Syndrome.

Meeting:
Dwarka, New Delhi, India
17-18 August, 2019
LIACON2019 and 4th Lipid Certification Course